CONSOLIDATED CONDENSED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 1,644.5	$ 1,136.1
Short-term investments (Note 5)	345.3	500.5
Accounts receivable, net of allowances of $13.9 and $8.3, respectively	778.3	771.5
Other receivables	56.1	56.6
Inventories (Note 2)	1,024.7	918.3
Prepaid expenses	110.2	128.8
Other current assets	252.1	224.9
Current assets of discontinued operations (Note 4)	304.8	299.0
Total current assets	4,516.0	4,035.7
Long-term investments (Note 5)	353.3	583.9
Property, plant, and equipment, net	1,640.1	1,592.8
Operating lease right-of-use assets	92.8	84.4
Goodwill	1,151.0	1,152.5
Other intangible assets, net	417.1	399.4
Deferred income taxes	832.6	749.4
Other assets (Note 2)	789.8	463.1
Non-current assets of discontinued operations (Note 4)	306.6	302.0
Total assets	10,099.3	9,363.2
Current liabilities
Accounts payable	185.9	186.6
Accrued and other liabilities (Note 2)	902.4	858.2
Operating lease liabilities	21.5	22.9
Current liabilities of discontinued operations (Note 4)	107.2	127.7
Total current liabilities	1,217.0	1,195.4
Long-term debt	597.3	597.0
Taxes payable	1.1	80.6
Operating lease liabilities	74.2	65.2
Uncertain tax positions	343.2	335.0
Litigation settlement accrual	74.8	94.2
Other liabilities	257.1	251.3
Non-current liabilities of discontinued operations (Note 4)	30.0	25.1
Total liabilities	2,594.7	2,643.8
Commitments and contingencies (Note 11)
Stockholders' equity
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding	0.0	0.0
Common stock, $1.00 par value, 1,050.0 shares authorized, 653.5 and 650.5 shares issued, and 602.3 and 601.1 shares outstanding, respectively	653.5	650.5
Additional paid-in capital	2,476.3	2,274.4
Retained earnings	9,710.6	8,992.4
Accumulated other comprehensive loss (Note 12)	(220.2)	(242.8)
Treasury stock, at cost, 51.2 and 49.4 shares, respectively	(5,182.8)	(5,024.5)
Total Edwards Lifesciences Corporation stockholders' equity	7,437.4	6,650.0
Noncontrolling interest	67.2	69.4
Total stockholders' equity	7,504.6	6,719.4
Total liabilities and equity	$ 10,099.3	$ 9,363.2